CNS Pharmaceuticals (CNSP) Return on Equity [ROE] (2019 - 2025)
CNS Pharmaceuticals' Return on Equity [ROE] was -221.74% in Q4 2025, up 91.37 percentage points from -313.11% a year earlier but down 107.00 percentage points from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Return on Equity [ROE] (2019 - 2025) Analysis & Trends
For FY2025, Return on Equity [ROE] at CNS Pharmaceuticals came in at -299.12%, up 1411.18 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -211.34 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -1710.30% in FY2024 (-690.02 pp), -1020.28% in FY2023 (-806.59 pp), -213.68% in FY2022 (-69.53 pp) and -144.15% in FY2021 (-56.37 pp).
- Quarterly Return on Equity [ROE] has moved between -5221.80% (Q3 2023) and -88.15% (Q1 2021) over five years.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 157.26 percentage points); the worst was Q3 2023 (a drop of 5075.17 percentage points).
- Per Business Quant data, CNSP's Return on Equity [ROE] in the three quarters before Q4 2025 was -114.74% (Q3 2025), -129.42% (Q2 2025) and -183.25% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | CNS Pharmaceuticals | 2.35 Mn | -39.89 Mn | - | -221.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -221.74% |
| Sep 30, 2025 | -114.74% |
| Jun 30, 2025 | -129.42% |
| Mar 31, 2025 | -183.25% |
| Dec 31, 2024 | -313.11% |
| Sep 30, 2023 | -5,221.80% |
| Jun 30, 2023 | -589.19% |
| Mar 31, 2023 | -293.42% |
| Dec 31, 2022 | -194.57% |
| Sep 30, 2022 | -146.63% |
| Jun 30, 2022 | -111.74% |
| Mar 31, 2022 | -139.36% |
| Dec 31, 2021 | -189.94% |
| Sep 30, 2021 | -132.48% |
| Jun 30, 2021 | -105.22% |
| Mar 31, 2021 | -88.15% |
| Dec 31, 2020 | -115.18% |
| Sep 30, 2020 | -289.73% |
| Jun 30, 2020 | -159.92% |
| Mar 31, 2020 | -83.48% |
API Access
CNS Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();